The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nuclear localization of EGF receptor and its potential new role as a transcription factor
Lin, S.-Y., Makino, K., Xia, W., Matin, A., Wen, Y., Kwong, K. Y., Bourguignon, L., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-802 · Cited by 1,064
The EGFR as a target for anticancer therapy—focus on cetuximab
Baselga, J. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00233-7 · Cited by 563
Huang, S., & Harari, P. M. (2000) · PubMed · Cited by 555
In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.
Milas, L., Mason, K. A., Hunter, N. R., et al. (2000) · PubMed · Cited by 503
Chan, D. W., Chen, B. P.-C., Prithivirajsingh, S., Kurimasa, A., Story, M. D., Qin, J., & Chen, D. J. (2002) · Genes & Development · doi:10.1101/gad.1015202 · Cited by 479
Mechanisms of DNA double strand break repair and chromosome aberration formation
Iliakis, G., Wang, H., Perrault, A. R., Boecker, W., Rosidi, B., Windhofer, F., Wu, W., Guan, J., Terzoudi, G., & Pantelias, G. (2004) · Cytogenetic and Genome Research · doi:10.1159/000077461 · Cited by 396
Repair of DNA double strand breaks by non-homologous end joining
Lees-Miller, S. (2003) · Biochimie · doi:10.1016/j.biochi.2003.10.011 · Cited by 366
Jeggo, P. A. (1998) · Advances in Genetics · doi:10.1016/s0065-2660(08)60144-3 · Cited by 361
Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy.
Mendelsohn, J. M. (1997) · PubMed · Cited by 344
The epidermal growth factor receptor as a target for cancer therapy.
Mendelsohn, J. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080003 · Cited by 330
Novel Prognostic Value of Nuclear Epidermal Growth Factor Receptor in Breast Cancer
Lo, H.-W., Xia, W., Wei, Y., Ali-Seyed, M., Huang, S.-F., & Hung, M.-C. (2005) · Cancer Research · doi:10.1158/0008-5472.338.65.1 · Cited by 290
Identification of Genes Involved in Repair of DNA Double-Strand Breaks in Mammalian Cells
Jeggo, P. A. (1998) · Radiation Research · doi:10.2307/3579810 · Cited by 283
Bandyopadhyay, D., Mandal, M., Adam, L., Mendelsohn, J., & Kumar, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1568 · Cited by 229
Molecular Mechanisms of Resistance to Therapies Targeting the Epidermal Growth Factor Receptor
Camp, E. R., Summy, J., Bauer, T. W., Liu, W., Gallick, G. E., & Ellis, L. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.397.11.1 · Cited by 210
Baumann, M., & Krause, M. (2004) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2004.07.007 · Cited by 176
Rothkamm, K., Kühne, M., Jeggo, P. A., & Löbrich, M. (2001) · PubMed · Cited by 151
Pharmacological background of EGFR targeting
Castillo, L., Étienne-Grimaldi, M.-C., Fischel, J., Formento, P., Magné, N., & Milano, G. A. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh257 · Cited by 119
Harari, P. M., & Huang, S. (2001) · Seminars in Radiation Oncology · doi:10.1053/srao.2001.26027 · Cited by 100
H2O2 is required for UVB-induced EGF receptor and downstream signaling pathway activation
Péus, D., Meves, A., Vasa, R. A., Beyerle, A., O’Brien, T., & Pittelkow, M. R. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00198-7 · Cited by 98
Bryant, P. E. (2004) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2004.07.005 · Cited by 82
Fenton, B. M., Paoni, S. F., & Ding, I. (2004) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2004.05.005 · Cited by 64
Chavaudra, N., Bourhis, J., & Foray, N. (2004) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2004.07.016 · Cited by 63
Manna, S. K., & Aggarwal, B. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203547 · Cited by 60
Gueven, N., Keating, K. E., Chen, P., Fukao, T., Khanna, K. K., Watters, D. J., Rodemann, H. P., & Lavin, M. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006190200 · Cited by 50
Self-citationOksvold, M. P., Thien, C. B. F., Widerberg, J., Chantry, A., Huitfeldt, H. S., & Langdon, W. Y. (2004) · Radiation Research · doi:10.1667/rr3185 · Cited by 17
Ismail, S. M., Buchholz, T. A., Story, M. D., Brock, W. A., & Stevens, C. W. (2004) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2004.07.003 · Cited by 10
Cited by
Understanding resistance to EGFR inhibitors—impact on future treatment strategies
Wheeler, D. L., Dunn, E. F., & Harari, P. M. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.97 · Cited by 683
Heger, M., van Golen, R. F., Broekgaarden, M., & Michel, M. C. (2014) · Pharmacological Reviews · doi:10.1124/pr.110.004044 · Cited by 576
Hatanpaa, K. J., Burma, S., Zhao, D., & Habib, A. A. (2010) · Neoplasia · doi:10.1593/neo.10688 · Cited by 471
Baselga, J., Gómez, P., Greil, R., Braga, S., Climent, M. A., Wardley, A. M., Kaufman, B., Stemmer, S. M., Pêgo, A., Chan, A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.2408 · Cited by 363
Focal adhesion signaling and therapy resistance in cancer
Eke, I., & Cordes, N. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.07.009 · Cited by 330
Metadata
- Authors
- Dittmann, K., Mayer, C., & Rodemann, H.-P.
- Venue
- Radiotherapy and Oncology
- Publisher
- Elsevier BV
- Published
- 2005-08
- Volume
- 76
- Issue
- 2
- Pages
- 157-161
- ISSN
- 0167-8140 (ISSN-L)
- OpenAlex
- W1964071325
- Cited by
- 287
- References
- 26
- FWCI
- 12.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.